The same study demonstrated that isolating anti-HSP60 antibodies from humans with coronary atherosclerosis and injecting them into apolipoprotein E-deficient mice caused significant increases in aortic atherosclerotic lesions [38]. Here, HSPD1 is linked to coronary atherosclerosis.